Home > News > pSivida receives patent for BioSilicon pills
July 26th, 2004
pSivida receives patent for BioSilicon pills
Abstract:
pSivida Limited (PSD) announced that its UK subsidiary has been granted a further Australian patent for BioSiliconTM. The patent relates to the invention of orally administrable pharmaceutical products that comprise porous and/or polycrystalline BioSilicon.